Ethynodiol diacetate (SC 11800) has been used for progestin supplementing therapy for obstetric and gynecologic diseases because of its strong progestin action.
Moreover, it has been used as an oral contraceptive because it has an ovulation inhibiting effect, on which many excellent clincial results have been reported.
The present paper deals with some consideration on its mode of action on the basis of its influence on the estrous cycle and contents of pituitary gonado tropin in the female rat.
MATERIALS AND METHODS
One hundred and seventy-six mature female Wistar strain rats, weighing more than 150 g and having regular estrous cycle, were used. During 2 weeks before the experiment, the vaginal smear was also collected at 9 o'clock in the morning and the estrous cycle during the treatment was observed.
SC 11800, progesterone, estradiol benzoate and testosterone propionate were each dis solved in sesame oil.
Each of the steroids was injected subcutaneously in a dose of 0.1 ml at the back of female rats every day for successive days. On the 22nd day the rats were sacrificed by decapitation and the pituitary was removed immediately.
After weighing the anterior lobe, it was homogenized in 0. prolactin after treatment with SC 11800 for a long time in the rat with normal estrous cycle. Our results showed a decrease in LH in proportion to the amount of the drug administered and a tendency of increase in prolactin, but no marked changes in FSH. Since the above findings were more marked than when progesterone was administered and the reaction was different from that by estrogen or testosterone, it is considered that SC 11800 interferes with the pituitary gonadotropin secretion and its action is different from that of progesterone. The pituitary gonadtoropin secretion is inhibited by several synthetic gestagens, especially norethynodrel and norethindrone, and these influences on the ovary are not blocked after administration of gonadotropin to the rat pretreated in such a way. These gestagens seem to inhibit hypophyseal functions directly not via a level in the ovaries (Saunders and Drill 1958, Epptein et al. 1958) , and SC 11800 is also considered to exhibit almost the same actions as these gestagens.
On the other hand, Stevens et al. (1965) reported that SC 11800 inhibited a peak of the LH appeared after the menstruation when it was administered to women at doses of 0.5, 1.0, and 2.0 mg. As we emphasized previously, it has been clarified that SC 11800, when employed in such a low dose that it could couplate but pregnant and does not to change remarkably the estrous cycle, does not inhibit hypophyseal functions markedly. Tokuda et al. (1967) found a relatively specific 32P uptake into the diencephalon and pituitary of the female rat with normal estrous cycle after treatment with SC 11800 for 30 days, and observed that 32P uptake into the hypophysis was lowered in proportion to the changes in ovarian weights. This indicates that SC 11800 acts on the diencephalon-pituitary system. However, Watanabe et al. (1968) pointed out that there was no tissue selectivity in 3H uptake into the organs of the female rat administered with 3H-labeled SC 11800. Therefore, the mechanism of inhibition of the diencephalon pituitary system by SC 11800 awaits further studies. 
